GoodRx Holdings Inc - Class A

GDRX NASDAQ Technology United States US38246G1085
2.81 $
6.48 %

Company offering a price comparison platform for prescription medications and discount services for consumers.

Price history of GoodRx Holdings Inc - Class A
Price history of GoodRx Holdings Inc - Class A

Performance & Momentum

6 Months 8.39 %
1 Year 22.05 %
3 Years 46.29 %
5 Years 92.00 %

Strategic Analysis

GoodRx Holdings Inc - Class A • 2026

GoodRx operates a price comparison and discount platform for prescription drugs, positioned at the intersection of consumers, pharmacies, and healthcare players. Its business model is built on price transparency and treatment cost optimization, with a simple value proposition that is highly sensitive to user adoption and trust.

Strengths
  • Clear positioning around controlling medication costs, a recurring and structural need in the United States
  • Light digital business model, easily scalable and focused on user acquisition and retention
  • Well-known brand in its niche, with a value proposition that is immediately understandable to the general public
Weaknesses
  • Dependence on a highly competitive market where differentiation may be limited
  • High sensitivity to growth pressure and user trust, with a very poor stock market track record
Momentum

Momentum is very weak and the trend remains clearly bearish, reflecting a persistent loss of market confidence. Recent performance shows marked underperformance across multiple horizons, suggesting a name that is more speculative than compelling at this stage. In the absence of favorable recent news, the stock remains in an unconfirmed recovery phase and requires tangible signs of operational stabilization.

Similar stocks to GoodRx Holdings Inc - Class A

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone